Acquired von Willebrand syndrome (AVWS) mainly presents as two distinct clinical and laboratory profiles, depending on the underlying blood condition,…
Articles by Steve Bryson PhD
New classes of second-line drugs targeting the immune pathways involved in the autoimmune attacks that cause immune thrombocytopenia (ITP)…
Incyte will acquire Vega Therapeutics, a subsidiary of Star Therapeutics, to advance the development of VGA039, an investigational monthly…
People with von Willebrand disease (VWD) had lower bone mineral density than healthy individuals in a small, single-center study,…
Heavy menstrual bleeding — a frequently reported symptom in women with von Willebrand disease (VWD) — is often overlooked…
Blocking the activity of an enzyme known as MELK may help boost the production of platelets — tiny cell fragments…
Six people with treatment-resistant immune thrombocytopenia (ITP) and underlying systemic lupus erythematosus (SLE) all achieved clinical responses to CAR…
A man’s severe case of treatment-resistant immune thrombotic thrombocytopenic purpura (iTTP) — which resulted in severe anemia despite more…
A new case study describes a family with platelet-type von Willebrand disease (PT-VWD), a rare bleeding condition often mistaken for…
A lack or delayed response to Cablivi (caplacizumab-yhdp), when used alongside standard therapy to treat acute episodes of immune-mediated…